SMITH & NEPHEW SMF AND REDAPT FEMORAL STEMS
In November 2016, Smith & Nephew, an orthopedic company based in Memphis, Tennessee, announced that it initiated a market removal for all lots of its modular SMF™ and REDAPT™ Revision Femoral Hip Systems. The company admitted that it had seen higher than expected rates of complaints and adverse events.
According to documents we obtained from regulatory authorities, Smith & Nephew sold the affected devices in the United States during the 8 year period between October 2008 and July 2016.
After selling these implants for almost a decade, Smith & Nephew finally issued an Urgent Field Safety Notice on November 15, 2016. In its letter to doctors, the company admitted that "Smith & Nephew considers that patients implanted with the modular neck hip prostheses may be at greater risk of revision surgery than with comparable monolithic products."
Modular femoral stems have been a big problem in orthopedics for years. Stryker Orthopedics had to recall two of its modular stems in 2012 because of very high failure rates. We have successfully represented clients in cases against Stryker, and the company has agreed to settle cases brought by thousands of victims of this product, paying over $1 billion in settlements to date. Most patients who underwent a revision of a Stryker modular stem were entitled to receive compensation of at least $300,000.
If you have a SMF™ or REDAPT™ femoral stem implanted in your hip, please contact us to discuss a potential claim against the manufacturer.
About Our Firm
At Seeger Salvas LLP, we have an unparalleled depth of knowledge about orthopedic implant litigation that is rooted in our years representing orthopedic companies. We now use that experience to represent victims who are injured by defective orthopedic implants.
Brian Devine, one of the firm's partners, worked for years at Sulzer Medica, a global manufacturer of hip and knee implants. As its Assistant General Counsel, Brian was responsible for all of the firm’s product liability cases worldwide. When the company suddenly had to recall several thousand hip and knee implants in December 2000, Brian was given lead responsibility for managing the resulting avalanche of litigation. He managed thousands of individual cases and directed attorneys in almost every state in the country. He then took a leading role in negotiating a nationwide class-action settlement which provided $1 billion in compensation to those who were injured by Sulzer Medica’s hip and knee implants.
Our legal and medical knowledge combined with our unique perspective we gained while representing companies in the medical device industry make us formidable adversaries. Our skill as advocates for our clients is best proven by our results. In the last few years alone, we have helped negotiate settlements for hip implant victims that are valued at more than $2.5 billion. We have been appointed to positions of leadership by state court and federal court judges across the country, and we have been key members of trial teams that have obtained awards ranging from $8 million to $1 billion on behalf of victims of defective hip implants.
Contact us today to learn more about our firm and our unique experience representing victims of defective orthopedic products.
Our description of your legal rights is not intended to imply that any product is defective. That can only be determined through a case-specific investigation. SMF and REDAPT are trademarks of Smith & Nephew and are used here for product identification purposes only. This site is not affiliated in any way with Smith & Nephew or any other manufacturer of orthopedic implants.